kidney disease and semaglutide FLOW clinical Trial (funded by Novo Nordisk): showed 24% reduction in A clinically meaningful reduction in

Do side effects get worse with each dose increase

The four-week intervals between dose increases allow your GI system to adapt, reducing the severity of side effects and improving long-term tolerability

The protocol for semaglutide is determined by your healthcare provider based on your individual needs and medical condition

Nausea, stomach pain, and diarrhea might improve as your body gets used to the medication

Over the roughly two years since the trials began, people with no prior history of stroke were less likely to experience one while being treated with semaglutide (dark blue) compared to those who received a placebo (light blue)